CO-1686 ≥98%|CAS:1374640-70-6|1 mg|5 mg|10 mg

AVL-301|CO-1686 is an inhibitor of mutant forms of EGFR, including T790M EGFR. CO-1686 exhibits anticancer chemotherapeutic activity, inducing tumor regression in animal models of non-small cell lung cancer (NSCLC) and sensitizing cancer cells in vitro to other chemotherapeutics.|C27H28F3N7O3|555.55||+4°C|